https://adjuvantcapital.com/news/portfolio/codagenix/ 2020-01-13T21:33:28+00:00 https://adjuvantcapital.com/news/portfolio/chromacode/ 2020-08-25T21:14:52+00:00 https://adjuvantcapital.com/news/portfolio/vitrivax/ 2021-01-22T19:29:40+00:00 https://adjuvantcapital.com/news/portfolio/evofem/ 2021-01-22T19:35:50+00:00 https://adjuvantcapital.com/news/portfolio/frontier-nutrition/ 2021-02-10T16:35:03+00:00 https://adjuvantcapital.com/news/portfolio/excision-biotherapeutics/ 2021-02-24T16:31:48+00:00 https://adjuvantcapital.com/news/portfolio/pulmocide/ 2021-09-09T21:32:57+00:00 https://adjuvantcapital.com/news/portfolio/themis/ 2021-10-26T12:43:39+00:00 https://adjuvantcapital.com/news/portfolio/antiva-biosciences/ 2021-12-14T16:17:17+00:00 https://adjuvantcapital.com/news/portfolio/curevo-vaccine/ 2022-02-15T22:04:59+00:00 https://adjuvantcapital.com/news/portfolio/memo-therapeutics/ 2022-02-16T12:57:58+00:00 https://adjuvantcapital.com/news/portfolio/minvervax/ 2023-10-24T15:17:07+00:00 https://adjuvantcapital.com/news/portfolio/limmatech-biologics/ 2023-10-24T15:25:40+00:00 https://adjuvantcapital.com/news/portfolio/quantoom/ 2026-05-20T19:05:09+00:00 https://adjuvantcapital.com/news/portfolio/univercells/ 2026-05-20T19:06:00+00:00 https://adjuvantcapital.com/news/portfolio/54gene/ 2026-05-20T19:07:08+00:00 https://adjuvantcapital.com/news/portfolio/x-vax/ 2026-05-20T19:12:16+00:00 https://adjuvantcapital.com/news/portfolio/indevr/ 2026-05-20T19:13:33+00:00 https://adjuvantcapital.com/news/portfolio/an2-therapeutics/ 2026-05-20T19:14:42+00:00